APOE and Alzheimer disease: In summary, the BOLD–CSF coupling was gradually weaker from the HC to SMC, to MCI, and then to AD groups, conditions known to show a gradually increasing severity of AD-related symptoms; it also appeared to be weaker in older participants, females, and APOE ε4 gene carriers, who are known to have a higher risk of developing AD pathology.